NCT04500470View on ClinicalTrials.gov

Ketoprofen With or Without Vaginal Isonicotinic Acid Hydrazide Prior to Hysterosalpingography

NACompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

July 30, 2021

Study Completion Date

September 1, 2021

Conditions

Infertility, Female

Interventions

DRUG

Ketoprofen + INH

patients will have of oral Ketoprofen 60 minutes before the procedure plus 3 table 900 mg vaginal isonicotinic acid hydrazide by the patient 12 hours before the procedure

DRUG

Ketoprofen + placebo

patients will have of oral Ketoprofen 60 minutes before the procedure plus 3 table placebo by the patient 12 hours before the procedure

Trial Locations (1)

81528

Aswan University Hospital, Aswān

All Listed Sponsors

lead

Aswan University Hospital

OTHER

NCT04500470 - Ketoprofen With or Without Vaginal Isonicotinic Acid Hydrazide Prior to Hysterosalpingography | Biotech Hunter | Biotech Hunter